Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients

Cardiovascular Research

Volumn 85, Issue 4, 2010, Pages 814-824

  Schlüter, Torsten ^a   Zimmermann, Uwe ^a   Protzel, Chris ^a,b   Miehe, Bärbel ^a   Klebingat, Klaus Jürgen ^a   Rettig, Rainer ^a   Grisk, Olaf ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b University Medicine Rostock   (Germany)

Author keywords

Arterial function; Endothelium; NADPH oxidase; Oxygen radicals; Renal function

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CATALASE; ENDOTHELIN 1; HYDROGEN PEROXIDE; LUCIGENIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE; TIRON; VASOPRESSIN;

AGED; ANIMAL TISSUE; ARCUATE ARTERY; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY RESISTANCE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISSECTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY TUMOR; MALE; MYOGRAPHY; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROXIMAL INTERLOBULAR ARTERY; RAT; RENAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TACHYPHYLAXIS; VASOCONSTRICTION; VASODILATATION;

1,2-DIHYDROXYBENZENE-3,5-DISULFONIC ACID DISODIUM SALT; AGED; AGED, 80 AND OVER; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROGEN PEROXIDE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NADPH OXIDASE; OXIDANTS; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; RENAL ARTERY; RNA, MESSENGER; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASOCONSTRICTION; VASODILATION;

EID: 76749148111     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp346     Document Type: Article

References (36)

1. Paravicini TM, Toyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71: 247-258.
2. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005;65:16-27.
3. Toyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT et al. Expression of the functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 2002;90:1205-1213.
4. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002;40:755-762.
5. Guzik TJ, Sadowski J, Kapelak B, Jopek A, Rudzinski P, Pillai R et al. Systemic regulation of vascular NAD(P)H oxidase activity and Nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol 2004;24: 1614-1620.
6. Schuijt MP, Tom B, de Vries R, Saxena PR, Sluiter W, van Kats JP et al. Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. J Hypertens 2003;21:2335-2344.
7. Cowley AW. Long-term control of arterial blood pressure. Physiol Rev 1992;72: 231-300.
8. Rettig R, Grisk O. The kidney as a determinant of genetic hypertension. Evidence from renal transplantation studies. Hypertension 2005;46:463-468.
9. Schnackenberg CG. Physiological and pathophysiological role of oxygen radicals in the renal microvasculature. Am J Physiol Regulatory Integrative Comp Physiol 2002;282:R335-R342.
10. 45Ca influx. Eur J Pharmacol 1985;106:47-52.
11. Maguire JJ, Kuc RE, O'Reilly G, Davenport AP. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol 1994;113: 49-54.
12. 1-adrenoceptor subtype mRNA and identification of subtype responsible for renovascular contraction in human renal artery. Life Sci 2000;66: 915-926.
13. Büssemaker E, Popp R, Binder J, Busse R, Fleming I. Characterization of the endothelium-derived hyperpolarizing factor (EDHF) in the human interlobar artery. Kidn Int 2003;63:1749-1755.
14. Grisk O, Lother U, Gabriëls G, Rettig R. Influence of neonatal sympathectomy on proximal renal resistance artery function in spontaneously hypertensive rats. Pflü-gers Arch-Eur J Physiol 2005;449:364-371.
15. Schlüter T, Steinbach AC, Steffen A, Rettig R, Grisk O. Apocynin-induced vasodi-lation involves Rho kinase inhibition but not NADPH oxidase inhibition. Cardio-vasc Res 2008;80:271-279.
16. Schlüter T, Grimm R, Steinbach A, Lorenz G, Rettig R, Grisk O. Neonatal sym-pathectomy reduces NADPH oxidase activity and vascular resistance in spontaneously hypertensive rat kidneys. Am J Physiol Regulatory Integrative Comp Physiol 2006;291:R391-R399.
17. Peirson SN, Butler JN, Foster RG. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucl Acids Res 2003; 31:e73.
18. Affolter JT, McKee SP, Helmy A, Jones CR, Newby DE, Webb DJ. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide. Clin Pharmacol Ther 2003;74:9-16.
19. 2+-entry pathways regulated by vasopressin. Biochem J 2003;370:439-448.
20. Hamel C, Millette A, Lamontagne D. Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in aortic rings. Life Sci 2005;77: 1069-1081.
21. Williams HC, Griendling KK. NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol 2007;50:9-16.
22. Grisk O, Heukäufer M, Steinbach A, Gruska S, Rettig R. Analysis of arterial pressure regulating systems in renal post-transplantation hypertension. J Hypertens 2004;22:199-207.
23. Sasser JM, Sullivan JC, Elmarakby AA, Kemp BE, Pollock DM, Pollock JS. Reduced NOS3/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2004;43:1080-1085.
24. Alvarez Y, Briones AM, Hernanz R, Pérez-Girón JV, Alonso MJ, Salaices M. Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. Br J Pharmacol 2008;153:926-935.
25. Burgoyone JR, Madhani M, Cuello F, Charles RL, Brennan JP, Schröder E et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007;317:1393-1397.
26. Demerci B, McKeown PP, Bayraktutan U. The bimodal regulation of vascular function by superoxide anion: role of endothelium. BMB Reports 2008;41: 223-229.
27. Ardanaz N, Pagano PJ. Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Exp Biol Med 2006;231: 237-251.
28. Thomas G, Ramwell P. Induction of vascular relaxation by hydroperoxides. Biochem Biophys Res Comm 1986;139:102-108.
29. Gao Y-J, Lee RMKW. Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 2005;146:1061-1068.
30. Lucchesi P, Belmadani S, Matrougi K. Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries. J Hypertens 2005;23:571-579.
31. Thakali K, Davenport L, Fink G, Watts SW. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats. Hypertension 2006;47:482-487.
32. 2+ and superoxide anion levels. J Pharmacol Exp Ther 2009;328:19-27.
33. Bors W, Saran M, Michel C. Pulse-radiolytic investigations of catechols and cat-echolamines. II. Reactions of tiron with oxygen radical species. Biochim Biophys Acta 1979;582:537-542.
34. Beckman JS, Minor RL, White CW, Repine JE, Rosen GM, Freeman BA. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J Biol Chem 1987;263:6884-6892.
35. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schröder K et al. Apocynin is not an inhibitor of vascular reduced nicotin-amide dinucleotide phosphate oxidases but an antioxidant. Hypertension 2008;51:211-217.
36. Xu H, Jackson WF, Fink GD, Galligan JJ. Activation of potassium channels by tempol in arterial smooth muscle cells from normotensive and deoxycorticoster-one acetate-salt hypertensive rats. Hypertension 2006;48:1080-1087.